Skip to content

Clinical trials

Phase 3 Cholangiocarcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Phase 3 Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20142
20172
20196
20232
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated7
Completed4
Recruiting3
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Concordia Laboratories Inc.1
Dan Zandberg1
Helsinn Healthcare SA1
Incyte Corporation1
InnoPharmax Inc.1
Institut de Recherches Internationales Servier1
J-Pharma Co., Ltd.1
Jazz Pharmaceuticals1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma17
Biliary Tract Neoplasms6
Gallbladder Neoplasms6
Bile Duct Neoplasms4
Klatskin Tumor2
Neoplasms2
Adenocarcinoma1
Anus Neoplasms1
Carcinoma, Hepatocellular1
Carcinoma, Merkel Cell1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.